Reports for Lallemand Pharma AG
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.Find out more
Economic information
Comprehensive information about the economic situation of a company.Find out more
Payment collection information
Overview of current and past debt enforcement proceedings.Find out more
Shareholder Information
Find out which national and international companies the stock corporation you are interested in also holds shares in.Find out more
Company dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.Retrieve company dossier
About Lallemand Pharma AG
- Lallemand Pharma AG has its legal headquarters in Massagno, is active and operates in the sector «Research and development».
- Lallemand Pharma AG has 3 persons entered in its management.
- On the 12.02.2020 the commercial register entry of the company was last changed. Under «Notifications» you will find all changes.
- The reported UID is the following: CHE-113.998.852.
- In the IPI there are 14 trademarks or applications registered by the company Lallemand Pharma AG.
Management (3)
newest board members
William John Nankervis,
Christian Sanchez,
Dr. Jean-Claude Villettaz
newest authorized signatories
William John Nankervis,
Christian Sanchez,
Dr. Jean-Claude Villettaz
Commercial register information
Entry in the commercial register
21.12.2007
Legal form
Company limited by shares (AG)
Legal headquarters of the company
Massagno
Commercial Registry Office
TI
Commercial register number
CH-501.3.009.848-4
UID/VAT
CHE-113.998.852
Sector
Research and development
Purpose (Original language)
Lo sviluppo, la commercializzazione, la distribuzione, la vendita e la registrazione di prodotti medicinali e farmaceutici per ogni tipo di applicazione nel mondo intero. Può esercitare attività e concludere accordi atti a promuovere lo scopo della società o che siano direttamente o indirettamente in relazione con lo stesso; in particolare partecipare a società con oggetto analogo in Svizzera e all'estero e acquisire, gestire e vendere beni mobili e immobili.
Auditor
Current auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| KPMG SA | Lausanne | 01.02.2016 | ||
Former auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| KPMG SA | Fribourg | 04.01.2008 | 31.01.2016 | |
Other company names
Past and translated company names
- Lallemand Pharma SA
- Lallemand Pharma Ltd
Branches (0)
Ownership structure
Holdings
Trademarks
| Trademark | Registration date | Status | Number |
|---|---|---|---|
| iComp | 15.05.2019 | active | 82832/2018 |
| iComp | 15.05.2019 | active | 82832/2018 |
Newest SOGC notifications: Lallemand Pharma AG
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1004828592, Commercial Registry Office Ticino, (501)
Lallemand Pharma AG, in Massagno, CHE-113.998.852, società anonima (Nr. FUSC 249 del 24.12.2019, Pubbl. 1004792713).
Nuove persone iscritte o modifiche:
Villettaz, Jean-Claude, da Grimisuat, in Sion, membro, con firma collettiva a due [finora: membro, con firma individuale].
Publication number: HR02-1004792713, Commercial Registry Office Ticino, (501)
Lallemand Pharma AG, in Massagno, CHE-113.998.852, società anonima (Nr. FUSC 151 del 08.08.2017, p.0, Pubbl. 3685417).
Statuti modificati:
16.12.2019.
Publication number: 3701155, Commercial Registry Office Zug
DRITTE VERÖFFENTLICHUNG
- Firma (Name) und Sitz des übernehmenden Rechtsträgers: Lallemand Pharma AG, Massagno
- Firma (Name) und Sitz des übertragenden Rechtsträgers: Lallemand Pharma International AG, Zug
- Publikation der Fusion: SHAB-Nr. 151 vom 08.08.2017
- Ablauf der Anmeldefrist für Forderungen: 3 Monate nach der Rechtswirksamkeit der Fusion
- Anmeldestelle für Forderungen: Lallemand Pharma AG, Via Selva 2, 6900 Massagno
- Hinweis: Die Gläubigerinnen und Gläubiger der an der Fusion beteiligten Gesellschaften können innerhalb von drei
Monaten nach der Rechtswirksamkeit der Fusion Sicherstellung ihrer Forderungen durch die übernehmende Gesellschaft verlangen.
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.